Evaluating continuous monitoring in Parkinson’s disease through real-world, device-reported outcomes.
Objective: This work presents an analysis of real-world, device-reported outcomes from patients in Greece, following a 6-month, continuous telemonitoring paradigm for Parkinson's disease. Results show…Development and validation of a new wearable device for the differential diagnosis of resting tremor
Objective: To develop a new easy-to-use wearable device to estimate the muscular contraction pattern of rest tremor (RT) using inertial data. Background: The RT pattern…A baseline study for the first year of a diverse Parkinson’s Disease interdisciplinary clinic
Objective: To characterize patients at a new diverse, academic Parkinson’s Disease (PD) interdisciplinary clinic (IDC). Background: PD affects patients in nearly all spheres of life,…Novelty Seeking: A Narrative Review
Objective: To explore novelty seeking (NS) as a construct, in both its adaptive and maladaptive roles, in order to provide insight into the cognitive and…Machine learning classifies Parkinson’s Disease and Progressive Supranuclear Palsy on saccade, pupil, and blink measures during a naturalistic free-viewing task
Objective: Eye tracking has been suggested as a source of prospective biomarkers in Parkinson’s Disease (PD), and recent work has demonstrated the use of machine…Informing people with Parkinson’s disease of their gene variant status: PD GENEration, a North American observational and registry study
Objective: To describe genetic testing results of major genes for Parkinson’s disease (PD) in a North American cohort as part of PD GENEration Background: Although…Prevalence of sleep disorders in patients with Parkinson’s disease undergoing screening: a retrospective study.
Objective: To determine the prevalence of sleep disorders in patients with Parkinson's disease undergoing sleep screening. Background: 2009 Norlina et al., determined the prevalence of…Preliminary Report on the Safety and Tolerability of Allogeneic Bone marrow-derived Mesenchymal Stem Cells as a disease-modifying therapy for Parkinson’s disease: Phase IIa double-blind, randomized controlled trial
Objective: To select the safest and most effective number of repeat doses of allogeneic mesenchymal stem cells (MSC) purified from bone marrow-derived from a healthy…Directional deep brain stimulation therapy in the long term
Objective: To describe our long-term clinical experience with directional deep brain stimulation (d-DBS) in patients with advanced Parkinson’s disease (PD) who have been implanted with…Autosomal dominant Parkinson’s disease caused by SNCA p.E46K variant in family with Russian ancestry: A case report
Objective: To report a family with autosomal dominant Parkinson’s disease (PD) with SNCA p.E46K variant. Background: Alpha-synuclein, encoded by SNCA, is a part of Lewy…
- « Previous Page
- 1
- …
- 139
- 140
- 141
- 142
- 143
- …
- 338
- Next Page »